The vast majority of Canadian biotech companies can't match the fund-raising power of big brother BioChem Pharma (BCHXF), which raised $159.3 million in a single follow-on offering last February. Nevertheless, like their U.S. counterparts, the smaller Canadian companies continue to raise the smaller sums necessary to keep them going.

Last week, three Canadian companies were active on the financing front, pocketing a total of US$5.8 million. Those include a $2.2 million placement by